FDA Inspection
Boston Medical Center CorporationBoston Medical Center Corporation – FDA Inspection, Sep 12, 2023
Record Details
This FDA Inspection record concerns Boston Medical Center Corporation, with an inspection on September 12, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 7934772d-2dac-4534-a116-47411800c3ed
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1218229
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Boston Medical Center Corporation
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 2, 2025 | Not classified | New England District Office | |
| May 16, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 18, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 3, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 27, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Boston Medical Center Corporation
- FDA Inspection 1270738 - 2025-05-02
- FDA Inspection 1091871 - 2019-05-16
- FDA Inspection 963517 - 2016-03-18
- FDA Inspection 864614 - 2014-02-03
- FDA Inspection 759061 - 2011-12-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.